Medical Eligibility Required Semaglutide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Semaglutide
The other rebuilds the tissue architecture that rapid fat loss puts under pressure
Socio-economic risk factors include lower income and an inability to adequately rest in the early weeks after developing COVID-19 (refs
The medical term for this process is delayed gastric emptying